TSE:LABS MediPharm Labs (LABS) Stock Price, News & Analysis → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free LABS Stock Alerts C$0.08 +0.01 (+14.29%) (As of 04/24/2024 ET) Add Compare Share Share Today's RangeC$0.08▼C$0.0950-Day RangeC$0.07▼C$0.1052-Week RangeC$0.06▼C$0.10Volume440,300 shsAverage Volume230,705 shsMarket CapitalizationC$32.10 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades Get MediPharm Labs alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About MediPharm Labs Stock (TSE:LABS)MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. It also provides GMP flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll products. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.Read More LABS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LABS Stock News HeadlinesMarch 28, 2024 | finance.yahoo.comMediPharm Labs Full Year 2023 Earnings: Revenues Beat Expectations, EPS LagsMarch 27, 2024 | finanznachrichten.deMediPharm Labs Corp.: MediPharm Labs Reports Fourth Quarter and Full Year ResultsApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.March 25, 2024 | finanznachrichten.deMediPharm Labs Corp.: MediPharm Labs Provides Update on German Cannabis LegalizationMarch 22, 2024 | finance.yahoo.comMediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial ResultsFebruary 26, 2024 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - LABS.WT.BFebruary 24, 2024 | msn.comMediPharm Labs (MEDIF) Price Target Increased by 5.07% to 0.08February 19, 2024 | theglobeandmail.comMediPharm Labs: Top 10 Undervalued Drug Manufacturers Industry Stocks (LABS)April 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.February 7, 2024 | ca.finance.yahoo.comStocks in play: MediPharm Labs Corp.December 25, 2023 | finance.yahoo.comLife Science REIT PLC (JL6.SG)December 22, 2023 | msn.comKey Leadership Changes In Cannabis You Should Know About As We Head Into 2024December 22, 2023 | markets.businessinsider.comCanadian Markets Might Open Slightly UpDecember 22, 2023 | finance.yahoo.comMediPharm Labs Provides Update on Board of Directors and Long Term Incentive ProgramDecember 20, 2023 | morningstar.comMediPharm Labs Corp LABSSeptember 27, 2023 | finance.yahoo.comMediPharm Labs Launches new GMP Products to the Australian Medical Cannabis MarketSeptember 20, 2023 | marketwatch.comMediPharm Labs Buys Out Royalty Agreement With Shelter Cannabis BrandsSeptember 20, 2023 | finance.yahoo.comMediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty AgreementAugust 31, 2023 | msn.comMedical cannabis may help manage fibromyalgia, study findsAugust 15, 2023 | theglobeandmail.comClosing Bell: Medipharm Labs Corp down on Tuesday (LABS)June 29, 2023 | finance.yahoo.comMediPharm Labs Announces Voting Results From the 2023 Annual Meeting of ShareholdersJune 22, 2023 | marketwatch.comNutritional, Vitamin and Food Supplement Analytical Services Market Overview By Share, And Product Demand Forecast Till 2029May 22, 2023 | theglobeandmail.comClosing Bell: Medipharm Labs Corp down on Friday (LABS)May 15, 2023 | msn.comMediPharm Labs Corp. Q1 Revenue Grows 20% YoY, Achieves First Quarter Of Positive Adjusted EBITDAMay 15, 2023 | finance.yahoo.comMediPharm Labs Reports First Quarter Results with Growth in Sales, Margin and EBITDAApril 19, 2023 | theglobeandmail.comClosing Bell: Medipharm Labs Corp up on Tuesday (LABS)April 17, 2023 | finance.yahoo.comMarket Participants Recognise MediPharm Labs Corp.'s (TSE:LABS) Revenues Pushing Shares 27% HigherSee More Headlines Receive LABS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:LABS CUSIPN/A CIKN/A Webwww.medipharmlabs.com Phone705 719 7425FaxN/AEmployees130Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-13,080,000.00 Net Margins-39.57% Pretax MarginN/A Return on Equity-24.00% Return on Assets-17.63% Debt Debt-to-Equity Ratio4.33 Current Ratio3.37 Quick Ratio3.10 Sales & Book Value Annual SalesC$33.06 million Price / Sales0.97 Cash FlowC$0.06 per share Price / Cash Flow1.30 Book ValueC$0.18 per share Price / Book0.44Miscellaneous Outstanding Shares401,280,000Free FloatN/AMarket CapC$32.10 million OptionableNot Optionable Beta1.04 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. David A. PidduckCEO & DirectorMr. Keith StrachanCo-Founder & PresidentMr. Greg HunterChief Financial OfficerMr. Patrick McCutcheonFounderMr. Saravan SubramaniamVice President of Operations & Supply ChainMr. Geoffrey MarrExecutive VP & General CounselMr. Brett MoonVice President of SalesMr. Kirk BinnsExecutive Vice President of Global AccountsMore ExecutivesKey CompetitorsMeta GrowthCVE:METAInMed PharmaceuticalsTSE:INZomedica Pharmaceuticals Corp. (ZOM.V)CVE:ZOMViridium Pacific GroupCVE:VIRMedexus PharmaceuticalsTSE:MDPView All Competitors LABS Stock Analysis - Frequently Asked Questions How have LABS shares performed in 2024? MediPharm Labs' stock was trading at C$0.07 on January 1st, 2024. Since then, LABS shares have increased by 23.1% and is now trading at C$0.08. View the best growth stocks for 2024 here. When is MediPharm Labs' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, June 28th 2024. View our LABS earnings forecast. What other stocks do shareholders of MediPharm Labs own? Based on aggregate information from My MarketBeat watchlists, some companies that other MediPharm Labs investors own include Cronos Group (CRON), Aurora Cannabis (ACB), Village Farms International (VFF), Canopy Growth (WEED), Aphria (APHA), Cresco Labs (CRLBF), HEXO (HEXO), Heat Biologics (HTBX), Absolute Software Co. (ABT.TO) (ABT) and Acasti Pharma (ACST). How do I buy shares of MediPharm Labs? Shares of LABS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:LABS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPharm Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
